Certified by Founder Lodge
Enavate Sciences
United States - ND
INVESTOR
1 Disclosed Funding Rounds $100,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the a
| Company | Date | Round | Raised |
|---|---|---|---|
CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
OrsoBio |
November, 08 ,2023 | Series A | $60,000,000 |
Sudo Biosciences |
December, 21 ,2023 | Series B | $116,000,000 |
Sionna Therapeutics |
March, 07 ,2024 | Series C | $182,000,000 |
Aviceda Therapeutics |
January, 08 ,2025 | Series C | $207,500,000 |
Normunity |
January, 14 ,2025 | Series B | $75,000,000 |
CAMP4 Therapeutics
OrsoBio
Sudo Biosciences
Sionna Therapeutics
Aviceda Therapeutics
Normunity
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
UPTIQ | $12,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)
iPNOTE - Your Virtual IP Paralegal | $1,000,000 | (Oct 29, 2025)
Cylerity | $4,000,000 | (Oct 29, 2025)
Syllo | $30,000,000 | (Oct 29, 2025)